Sanara MedTech Inc. (SMTI)

$ 32.71
-1.26 (-3.71%)
-
Symbol SMTI
Price $ 32.71
Beta 2.244
Volume Avg. 0.01M
Market Cap 0.25B
Shares () -
52 Week Range 21.3-53.85
1y Target Est -
DCF Unlevered SMTI DCF ->
DCF Levered SMTI LDCF ->
ROE -18.25% Sell
ROA -9.66% Neutral
Operating Margin -
Debt / Equity 11.91% Neutral
P/E -
P/B 7.08 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SMTI news


Mr. Michael D. McNeil
Healthcare
Medical Care Facilities
Nasdaq Capital Market

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder that helps in the natural wound healing process; Biako¯s Antimicrobial Skin & Wound Cleanser, a patented wound cleansing spray that disrupts extracellular polymeric substances to eradicate biofilm; and Biako¯s Antimicrobial Skin & Wound Irrigation Solution that works to irrigate and remove microbes from the wound bed to help eliminate planktonic, immature, and mature biofilms. It also provides Biako¯s Antimicrobial Wound Gel, a patented gel that synergistically disrupts extracellular polymeric substances to help eliminate biofilm microbes in the gel to help in wound healing; HYCOL Hydrolyzed Collagen, an additive free Type I bovine collagen that offers hydrolyzed collagen fragments to the wound bed that are a fraction of the size of native collagen; and PULSAR II Advanced Wound Irrigation Debridement System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.